| Prestation | Nom de la Société | Ville | Date |
|---|---|---|---|
| Pharmacovigilance | MBR Consulting | Varsovie |
TBD |
| Pharmacovigilance | Medi-Regist Ltd | Visegradi |
TBD |
| Distribution | METROPOLIS | Naxxar |
TBD |
| Distribution | PHARMAMEDIC | Beyrouth |
TBD |
| Distribution | TEDIS | HCMC |
TBD |
| Autres | EVOK | Fribourg |
TBD |
| Autres | BOSPHORE SENSE | Lyon |
TBD |
| Principe actif (API) | EVONIK | Dosenheim |
TBD |
| Produit fini | PHARMATIS | ESTREES ST DENIS |
TBD |
| Distribution | CSP BE | Houdeng-Goegnies |
TBD |
| Autres | HEALTY MIND | Paris |
TBD |
| Autres | IRON MOUNTAIN | Mignières |
05/02/2026 |
| Analyses | SGS INSTITUT FRESENIUS GmbH | Taunusstein |
TBD |
| Article de conditionnement secondaire (AC II) | MPS- Smurfit Westrock | Ussel |
03/02/2026 |
| Autres | BOOSTER PHARMA | CHAMPS-SUR-MARNE |
TBD |
| Autres | PHARMAFIELD | Neuilly‑sur‑Seine |
TBD |
